Mackenzie Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.6M Sell
1,203,945
-8,019
-0.7% -$558K 0.09% 191
2025
Q4
$81.1M Buy
1,211,964
+106,320
+10% +$6.87M 0.1% 182
2025
Q3
$74.4M Buy
1,105,644
+87,623
+9% +$6.93M 0.09% 193
2025
Q2
$88.9M Sell
1,018,021
-43,245
-4% -$3.39M 0.12% 161
2025
Q1
$72.5M Sell
1,061,266
-235,512
-18% -$19.2M 0.1% 176
2024
Q4
$101M Buy
1,296,778
+1,407
+0.1% +$104K 0.14% 147
2024
Q3
$86.8M Buy
1,295,371
+474,179
+58% +$38.9M 0.12% 155
2024
Q2
$93.1M Buy
821,192
+74,473
+10% +$9.42M 0.14% 143
2024
Q1
$104M Sell
746,719
-2,933
-0.4% -$369K 0.15% 142
2023
Q4
$93M Buy
749,652
+95,829
+15% +$9.79M 0.14% 142
2023
Q3
$59.5M Buy
653,823
+153,556
+31% +$17.3M 0.1% 172
2023
Q2
$63.5M Sell
500,267
-31,106
-6% -$3.76M 0.1% 178
2023
Q1
$61.7M Sell
531,373
-23,009
-4% -$2.58M 0.1% 189
2022
Q4
$62.8M Buy
554,382
+36,108
+7% +$3.96M 0.1% 178
2022
Q3
$41.7M Buy
518,274
+80,678
+18% +$6.83M 0.07% 220
2022
Q2
$32.6M Buy
437,596
+319,532
+271% +$29.2M 0.05% 260
2022
Q1
$15.1M Buy
118,064
+24,640
+26% +$2.7M 0.02% 407
2021
Q4
$12.5M Buy
93,424
+14,872
+19% +$2.14M 0.02% 446
2021
Q3
$10.7M Buy
78,552
+3,380
+4% +$426K 0.02% 452
2021
Q2
$8.03M Buy
75,172
+3,508
+5% +$337K 0.01% 486
2021
Q1
$6.44M Buy
71,664
+6,120
+9% +$574K 0.01% 490
2020
Q4
$6.06M Buy
65,544
+6,468
+11% +$578K 0.01% 413
2020
Q3
$6.09M Sell
59,076
-10,612
-15% -$1.11M 0.02% 375
2020
Q2
$7.06M Sell
69,688
-3,460
-5% -$310K 0.02% 343
2020
Q1
$4.92M Sell
73,148
-2,096,612
-97% -$130M 0.02% 349
2019
Q4
$119M Sell
2,169,760
-1,015,608
-32% -$48.2M 0.29% 91
2019
Q3
$119M Sell
3,185,368
-158,536
-5% -$6.16M 0.31% 83
2019
Q2
$125M Sell
3,343,904
-979,640
-23% -$30.8M 0.32% 81
2019
Q1
$129M Buy
4,323,544
+1,251,660
+41% +$44M 0.31% 78
2018
Q4
$92M Buy
3,071,884
+369,156
+14% +$11.7M 0.24% 102
2018
Q3
$96.7M Sell
2,702,728
-1,362,472
-34% -$42.2M 0.24% 115
2018
Q2
$96.5M Sell
4,065,200
-1,648,360
-29% -$34.9M 0.25% 102
2018
Q1
$106M Buy
5,713,560
+227,180
+4% +$3.36M 0.27% 77
2017
Q4
$78.7M Buy
5,486,380
+351,392
+7% +$4.57M 0.19% 106
2017
Q3
$62.8M Buy
5,134,988
+631,848
+14% +$11.2M 0.34% 82
2017
Q2
$82.4M Buy
4,503,140
+785,616
+21% +$14.5M 0.46% 54
2017
Q1
$78.7M Sell
3,717,524
-213,232
-5% -$4.16M 0.46% 59
2016
Q4
$58.7M Buy
3,930,756
+1,070,528
+37% +$19M 0.35% 75
2016
Q3
$62.7M Sell
2,860,228
-132,504
-4% -$2.95M 0.39% 72
2016
Q2
$59.4M Buy
2,992,732
+98,080
+3% +$1.67M 0.34% 76
2016
Q1
$49.1M Buy
2,894,652
+545,080
+23% +$9.11M 0.45% 50
2015
Q4
$48.1M Buy
2,349,572
+185,600
+9% +$3.86M 0.3% 84
2015
Q3
$46.5M Buy
2,163,972
+67,200
+3% +$1.5M 0.28% 82
2015
Q2
$41.9M Sell
2,096,772
-68,640
-3% -$1.21M 0.23% 105
2015
Q1
$33.7M Buy
2,165,412
+260,260
+14% +$3.93M 0.18% 136
2014
Q4
$26.2M Sell
1,905,152
-83,996
-4% -$1.03M 0.13% 150
2014
Q3
$19.9M Sell
1,989,148
-58,736
-3% -$600K 0.1% 181
2014
Q2
$20.3M Buy
2,047,884
+140,896
+7% +$1.25M 0.09% 196
2014
Q1
$19.7M Sell
1,906,988
-142,180
-7% -$1.47M 0.1% 185
2013
Q4
$18.1M Sell
2,049,168
-346,660
-14% -$2.74M 0.09% 195
2013
Q3
$16.9M Sell
2,395,828
-2,940,636
-55% -$18.6M 0.09% 198
2013
Q2
$30M Buy
+5,336,464
New +$25.6M 0.14% 165

Other funds holding DXCM

Mackenzie Financial's DXCM Position: Q1 2026 in Review

Mackenzie Financial reduced its DexCom (DXCM) stake by 0.66% in Q1 2026, selling an estimated $558K and leaving 1,203,945 shares worth $75.6M. The position accounts for 0.09% of the portfolio, ranked #191.

Mackenzie Financial first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $129M in Q1 2019. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Mackenzie Financial held 1,203,945 shares of DexCom worth $75.6M as of Q1 2026.
  • Mackenzie Financial sold 8,019 DexCom shares in Q1 2026, an estimated $558K.
  • DexCom made up 0.09% of Mackenzie Financial's portfolio in Q1 2026, its #191 holding.
  • Mackenzie Financial first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
  • Mackenzie Financial's DexCom position peaked at $129M in Q1 2019.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.